Uwe Wintergerst

9.0k total citations
65 papers, 1.3k citations indexed

About

Uwe Wintergerst is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Uwe Wintergerst has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 25 papers in Epidemiology and 23 papers in Virology. Recurrent topics in Uwe Wintergerst's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (14 papers). Uwe Wintergerst is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (20 papers) and HIV/AIDS Research and Interventions (14 papers). Uwe Wintergerst collaborates with scholars based in Germany, United States and Netherlands. Uwe Wintergerst's co-authors include Gundula Notheis, Bernd H. Belohradsky, Annette Jansson, Martin Aepfelbacher, Stefan Linder, Katharina Hüfner, Florian Hoffmann, B. H. Belohradsky, Theoni Petropoulou and Verena Jendrossek and has published in prestigious journals such as Nature Communications, Blood and Journal of Cell Science.

In The Last Decade

Uwe Wintergerst

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Wintergerst Germany 20 548 379 284 266 217 65 1.3k
C. Baboonian United Kingdom 20 382 0.7× 471 1.2× 113 0.4× 668 2.5× 432 2.0× 38 2.5k
R. Viraben France 20 303 0.6× 103 0.3× 180 0.6× 344 1.3× 106 0.5× 85 1.2k
J. Bruce Sundstrom United States 22 628 1.1× 548 1.4× 223 0.8× 527 2.0× 141 0.6× 39 1.9k
José Menézes Canada 25 323 0.6× 1.1k 2.9× 322 1.1× 590 2.2× 265 1.2× 76 2.0k
Julio C. Delgado United States 23 521 1.0× 1.2k 3.2× 176 0.6× 522 2.0× 287 1.3× 43 2.3k
Pedro O. Flores-Villanueva United States 21 317 0.6× 588 1.6× 226 0.8× 239 0.9× 197 0.9× 29 1.4k
Teresa Español Spain 26 477 0.9× 1.6k 4.3× 141 0.5× 463 1.7× 220 1.0× 67 2.3k
Caterina Cancrini Italy 24 227 0.4× 1.1k 3.0× 161 0.6× 298 1.1× 390 1.8× 96 1.9k
J. D’Amaro Netherlands 24 158 0.3× 700 1.8× 94 0.3× 217 0.8× 104 0.5× 64 1.5k
Thomas M. McHugh United States 22 489 0.9× 806 2.1× 816 2.9× 482 1.8× 240 1.1× 36 2.1k

Countries citing papers authored by Uwe Wintergerst

Since Specialization
Citations

This map shows the geographic impact of Uwe Wintergerst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Wintergerst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Wintergerst more than expected).

Fields of papers citing papers by Uwe Wintergerst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Wintergerst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Wintergerst. The network helps show where Uwe Wintergerst may publish in the future.

Co-authorship network of co-authors of Uwe Wintergerst

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Wintergerst. A scholar is included among the top collaborators of Uwe Wintergerst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Wintergerst. Uwe Wintergerst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lui, Julian C., Adalbert Raimann, Hironori Hojo, et al.. (2022). A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder. Nature Communications. 13(1). 700–700. 22 indexed citations
2.
Raimann, Adalbert, Julian C. Lui, Paul Roschger, et al.. (2019). De novo Missense Mutation in SP7 in a Patient with Cranial Hyperostosis, Long Bone Fragility, and Increased Osteoblast Number. 92. 2 indexed citations
3.
Rack, Anita, B. H. Belohradsky, R. Grantzow, et al.. (2016). Inflammatory pseudotumor (IPT)—surgical cure of an inflammatory syndrome. European Journal of Pediatrics. 175(7). 903–908. 2 indexed citations
4.
Pannicke, Ulrich, Ellen D. Renner, Gundula Notheis, et al.. (2010). Successful Long-Term Correction of Autosomal Recessive Hyper-IgE Syndrome due to DOCK8 Deficiency by Hematopoietic Stem Cell Transplantation. Klinische Pädiatrie. 222(6). 351–355. 52 indexed citations
5.
Hartl, Dominik, Florian Hoffmann, Annette Jansson, et al.. (2008). Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. Journal of Allergy and Clinical Immunology. 121(2). 375–382.e9. 43 indexed citations
6.
Humbert, Michael, Boris Brill, Berta Rodés, et al.. (2007). Mimotopes selected with antibodies from HIV‐1‐neutralizing long‐term non‐progressor plasma. European Journal of Immunology. 37(2). 501–515. 29 indexed citations
7.
Notheis, Gundula, Luigi Tarani, Francesco Costantino, et al.. (2006). Posaconazole for treatment of refractory invasive fungal disease. Mycoses. 49(s1). 37–41. 38 indexed citations
8.
Boer, Martin de, Dominik Hartl, Uwe Wintergerst, Bernd H. Belohradsky, & Dirk Roos. (2005). A donor splice site mutation in intron 1 of CYBA, leading to chronic granulomatous disease. Blood Cells Molecules and Diseases. 35(3). 365–369. 6 indexed citations
9.
Urschel, Simon, José Manuel Ramos, María José Mellado, et al.. (2005). Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy. AIDS. 19(18). 2103–2108. 12 indexed citations
10.
Hoffmann, Florian, Michael Kurowski, Hartmut Stocker, et al.. (2004). Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected children. AIDS. 18(10). 1473–1475. 3 indexed citations
11.
Linde, R., Markus B. Funk, Tobias Schuster, et al.. (2001). Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy. AIDS. 15(8). 1077–1079. 4 indexed citations
12.
Böhler, Thomas, Uwe Wintergerst, R. Linde, Bernd H. Belohradsky, & Klaus‐Michael Debatin. (2001). CD95 (APO-1/Fas) Expression on Naive CD4+ T Cells Increases with Disease Progression in HIV-Infected Children and Adolescents: Effect of Highly Active Antiretroviral Therapy (HAART). Pediatric Research. 49(1). 101–110. 9 indexed citations
13.
Wintergerst, Uwe, et al.. (2000). Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children. AIDS. 14(12). 1866–1868. 11 indexed citations
14.
Hoffmann, Florian, Gundula Notheis, Uwe Wintergerst, et al.. (2000). Comparison of ritonavir plus saquinavir- and nelfinavir plus saquinavir-containing regimens as salvage therapy in children with human immunodeficiency type 1 infection. The Pediatric Infectious Disease Journal. 19(1). 47–51. 23 indexed citations
15.
Liese, Johannes G., Verena Jendrossek, Theoni Petropoulou, et al.. (2000). Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. The Journal of Pediatrics. 137(5). 687–693. 139 indexed citations
16.
Wintergerst, Uwe, Florian Hoffmann, B. Sölder, et al.. (1998). Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus. The Pediatric Infectious Disease Journal. 17(6). 495–499. 44 indexed citations
17.
18.
Rolinski, Boris, et al.. (1997). Absorption and Elimination Kinetics of Zidovudine in the Cerebrospinal Fluid in HIV-1-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(3). 192–197. 38 indexed citations
19.
Wintergerst, Uwe & B. H. Belohradsky. (1992). Acyclovir monotherapy versus acyclovir plus beta-interferon in focal viral encephalitis in children. Infection. 20(4). 207–212. 8 indexed citations
20.
Wintergerst, Uwe, Urs Meyer, K. Remberger, & B. H. Belohradsky. (1989). [Graft versus host reaction in an infant with DiGeorge syndrome].. PubMed. 137(6). 345–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Baboonian Breakdown of academic impact, for papers by R. Viraben Breakdown of academic impact, for papers by J. Bruce Sundstrom Breakdown of academic impact, for papers by José Menézes Breakdown of academic impact, for papers by Julio C. Delgado Breakdown of academic impact, for papers by Pedro O. Flores-Villanueva Breakdown of academic impact, for papers by Teresa Español Breakdown of academic impact, for papers by Caterina Cancrini Breakdown of academic impact, for papers by J. D’Amaro Breakdown of academic impact, for papers by Thomas M. McHugh
Rankless by CCL
2026